Sophie Métivier - Concepedia

Author

Sophie Métivier

Also Known As

Anne Laurain, K Barange, K. Barange, L. Alric, M. Sophie, METIVIER Sophie, Magda Meszaros, Marie-Laure Lucas, Metivier Sophie, Metivier, Sophie

135

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Inserm Assistance Publique – Hôpitaux de Paris Hôpital Purpan Sorbonne Université Université Paris Cité

About

Sophie Métivier is an author at Inserm specializing in medicine, viral hepatitis, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	3.1K
2	Epidemiology	9	9	1.2K
3	Health Sciences	3	3	377
4	Public Health	3	3	642
5	Biostatistics	1	1	55

Sophie Métivier

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study Fabrice Carrat, Hélène Fontaine, Céline Dorival, The Lancet HepatologyHepatitis CViral HepatitisClinical EpidemiologyChronic Hepatitis C	2019	612
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890 Christophe Hézode, Hélène Fontaine, Céline Dorival, Journal of Hepatology HepatologyAnrs Co20-cupicViral HepatitisTriple TherapyHepatitis	2013	431
Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease C. Bureau, Sophie Métivier, Jean Marie Péron, Alimentary Pharmacology & Therapeutics	2008	364
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study Michael Manns, S. Pol, Ira M. Jacobson, The Lancet Multicohort StudyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy	2014	343
Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study Marie Angèle Robic, Bogdan Procopeț, Sophie Métivier, Journal of Hepatology HypertensionUrologyHepatologyLiver PhysiologyPortal Hypertension	2011	306
Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long‐term results of a randomized multicentre study Christophe Bureau, Juan Carlos García‐Pagán, Gilles Pomier Layrargues, Liver International	2007	305
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS) Marc Bourlière, Jean-Pierre Bronowicki, Victor de Lédinghen, The Lancet Infectious Diseases HepatologyViral HepatitisAntiviral Drug DevelopmentHcv Genotype 1Hepatitis	2015	280
Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis Christophe Hézode, Hélène Fontaine, Céline Dorival, Gastroenterology HepatologyHepatitis CViral HepatitisHcv Genotype 1Hepatitis	2014	259
Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation Nassim Kamar, Olivier Marion, Lionel Rostaing, American Journal of Transplantation TransplantationHepatologyHepatitis CKidney TransplantViral Hepatitis	2015	199
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta Dominique Roulot, Ségolène Brichler, Richard Layese, Journal of Hepatology Hepatitis DViral PersistenceHepatologyViral HepatitisHdv Genotype	2020	145

Page 1